SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Zhi-Liang Duan, Hui-Fang Liu, Xi Huang, Si-Na Wang, Jin-Lin Yang, Xin-Yu Chen, De-Zhou Li, Xiao-Zhi Zhong, Bo-Kun Chen, Jin-Sheng Wen, Identification of conserved and HLA-A*2402-restricted epitopes in Dengue virus serotype 2, Virus Research, 2015, 196, 5

    CrossRef

  2. 2
    J. E. Fraser, S. Watanabe, C. Wang, W. K. K. Chan, B. Maher, A. Lopez-Denman, C. Hick, K. M. Wagstaff, J. M. Mackenzie, P. M. Sexton, S. G. Vasudevan, D. A. Jans, A Nuclear Transport Inhibitor That Modulates the Unfolded Protein Response and Provides In Vivo Protection Against Lethal Dengue virus Infection, Journal of Infectious Diseases, 2014, 210, 11, 1780

    CrossRef

  3. 3
    Rafael Elias Marques, Rodrigo Guabiraba, Daniel Cisalpino, Mauro M. Teixeira, Danielle G. Souza, Dengue, Colloquium Series on Integrated Systems Physiology: From Molecule to Function, 2014, 6, 1, 1

    CrossRef

  4. 4
    Anuja Mathew, Elizabeth Townsley, Francis A Ennis, Elucidating the role of T cells in protection against and pathogenesis of dengue virus infections, Future Microbiology, 2014, 9, 3, 411

    CrossRef

  5. 5
    R. Ben-Shachar, K. Koelle, Minimal within-host dengue models highlight the specific roles of the immune response in primary and secondary dengue infections, Journal of The Royal Society Interface, 2014, 12, 103, 20140886

    CrossRef

  6. 6
    Hannah Woodall, Ben Adams, Partial cross-enhancement in models for dengue epidemiology, Journal of Theoretical Biology, 2014, 351, 67

    CrossRef

  7. 7
    Laura F. Su, Mark M. Davis, Antiviral memory phenotype T cells in unexposed adults, Immunological Reviews, 2013, 255, 1
  8. 8
    Lara J. Herrero, Andrew Zakhary, Michelle E. Gahan, Michelle A. Nelson, Belinda L. Herring, Andrew J. Hapel, Paul A. Keller, Maheshi Obeysekera, Weiqiang Chen, Kuo-Ching Sheng, Adam Taylor, Stefan Wolf, Jayaram Bettadapura, Shobha Broor, Lalit Dar, Suresh Mahalingam, Dengue virus therapeutic intervention strategies based on viral, vector and host factors involved in disease pathogenesis, Pharmacology & Therapeutics, 2013, 137, 2, 266

    CrossRef

  9. 9
    Tomoyuki Yoshida, Tsutomu Omatsu, Akatsuki Saito, Yuko Katakai, Yuki Iwasaki, Terue Kurosawa, Masataka Hamano, Atsunori Higashino, Shinichiro Nakamura, Tomohiko Takasaki, Yasuhiro Yasutomi, Ichiro Kurane, Hirofumi Akari, Dynamics of cellular immune responses in the acute phase of dengue virus infection, Archives of Virology, 2013, 158, 6, 1209

    CrossRef

  10. 10
    Sneha Ganu, Yesha Mehta, Femoral compressive neuropathy from iliopsoas haematoma complicating dengue hemorrhagic fever, Asian Pacific Journal of Tropical Medicine, 2013, 6, 5, 419

    CrossRef

  11. 11
    Jie Yang, Lingyun Zou, Zhen Hu, Wei Chen, Junlei Zhang, Junmin Zhu, Xin Fang, Wenchang Yuan, Xiaomei Hu, Fuquan Hu, Xiancai Rao, Identification and characterization of a 43 kDa actin protein involved in the DENV-2 binding and infection of ECV304 cells, Microbes and Infection, 2013, 15, 4, 310

    CrossRef

  12. 12
    Anusyah Rathakrishnan, Shamala Devi Sekaran, New development in the diagnosis of dengue infections, Expert Opinion on Medical Diagnostics, 2013, 7, 1, 99

    CrossRef

  13. 13
    Anke Harenberg, Sarah Begue, Audrey Mamessier, Sophie Gimenez-Fourage, Ching Ching Seah, Ai Wei Liang, Jun Li Ng, Xue Yun Toh, Sophia Archuleta, Annelies Wilder-Smith, Lynette P Shek, Anh Wartel-Tram, Alain Bouckenooghe, Jean Lang, Denis Crevat, Catherine Caillet, Bruno Guy, Persistence of Th1/Tc1 responses one year after tetravalent dengue vaccination in adults and adolescents in Singapore, Human Vaccines & Immunotherapeutics, 2013, 9, 11, 2317

    CrossRef

  14. 14
    Maria G. Guzman, Mayling Alvarez, Scott B. Halstead, Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection, Archives of Virology, 2013, 158, 7, 1445

    CrossRef

  15. 15
    Gathsaurie Neelika Malavige, Graham S. Ogg, T cell responses in dengue viral infections, Journal of Clinical Virology, 2013, 58, 4, 605

    CrossRef

  16. 16
    Peifang Sun, Tadeusz J. Kochel, The Battle between Infection and Host Immune Responses of Dengue Virus and Its Implication in Dengue Disease Pathogenesis, The Scientific World Journal, 2013, 2013, 1

    CrossRef

  17. 17
    Rosmari Rodriguez-Roche, Ernest A. Gould, Understanding the Dengue Viruses and Progress towards Their Control, BioMed Research International, 2013, 2013, 1

    CrossRef

  18. 18
    Denis Leonardo Fontes Jardim, Daniela Miti Lemos Tsukumo, Rodrigo N. Angerami, Marco Antonio de Carvalho Filho, Mário José Abdalla Saad, Autoimmune features caused by dengue fever: a case report, The Brazilian Journal of Infectious Diseases, 2012, 16, 1, 92

    CrossRef

  19. 19
    Tomoyuki Yoshida, Tsutomu Omatsu, Akatsuki Saito, Yuko Katakai, Yuki Iwasaki, Sayuki Iijima, Terue Kurosawa, Masataka Hamano, Shinichiro Nakamura, Tomohiko Takasaki, Yasuhiro Yasutomi, Ichiro Kurane, Hirofumi Akari, CD16+ natural killer cells play a limited role against primary dengue virus infection in tamarins, Archives of Virology, 2012, 157, 2, 363

    CrossRef

  20. You have free access to this content20
    Smita Jaiswal, Pamela Pazoles, Marcia Woda, Leonard D. Shultz, Dale L. Greiner, Michael A. Brehm, Anuja Mathew, Enhanced humoral and HLA-A2-restricted dengue virus-specific T-cell responses in humanized BLT NSG mice, Immunology, 2012, 136, 3
  21. 21
    Laura Mónica Álvarez-Rodríguez, Angel Ramos-Ligonio, José Luis Rosales-Encina, María Teresa Martínez-Cázares, Aurora Parissi-Crivelli, Aracely López-Monteon, Expression, Purification, and Evaluation of Diagnostic Potential and Immunogenicity of a Recombinant NS3 Protein from All Serotypes of Dengue Virus, Journal of Tropical Medicine, 2012, 2012, 1

    CrossRef

  22. 22
    Xin Fang, Zhen Hu, Weilong Shang, Junmin Zhu, Chuanshan Xu, Xiancai Rao, Genetic polymorphisms of molecules involved in host immune response to dengue virus infection, FEMS Immunology & Medical Microbiology, 2012, 66, 2
  23. 23
    Zhi-Liang Duan, Qiang Li, Zhi-Bin Wang, Ke-Dong Xia, Jiang-Long Guo, Wen-Quan Liu, Jin-Sheng Wen, HLA-A*0201-restricted CD8+ T-cell epitopes identified in dengue viruses, Virology Journal, 2012, 9, 1, 259

    CrossRef

  24. 24
    J. Tian, G. Zeng, X. Pang, M. Liang, J. Zhou, D. Fang, Y. Liu, D. Li, L. Jiang, Identification and immunogenicity of two new HLA-A*0201-restricted CD8+ T-cell epitopes on dengue NS1 protein, International Immunology, 2012, 24, 4, 207

    CrossRef

  25. 25
    G. N. Malavige, S. McGowan, V. Atukorale, M. Salimi, M. Peelawatta, N. Fernando, S. D. Jayaratne, G. Ogg, Identification of serotype-specific T cell responses to highly conserved regions of the dengue viruses, Clinical & Experimental Immunology, 2012, 168, 2
  26. 26
    Rosmari Rodriguez-Roche, Elci Villegas, Shelley Cook, Pauline A.W. Poh Kim, Yoandri Hinojosa, Delfina Rosario, Iris Villalobos, Herminia Bendezu, Martin L. Hibberd, Maria G. Guzman, Population structure of the dengue viruses, Aragua, Venezuela, 2006–2007. Insights into dengue evolution under hyperendemic transmission, Infection, Genetics and Evolution, 2012, 12, 2, 332

    CrossRef

  27. 27
    Alma Ortiz, Zeuz Capitan, Yaxelis Mendoza, Julio Cisneros, Brechla Moreno, Yamitzel Zaldivar, Mariana Garcia, Rebecca E. Smith, Jorge Motta, Juan Miguel Pascale, Simple, specific molecular typing of dengue virus isolates using one-step RT-PCR and restriction fragment length polymorphism, Journal of Virological Methods, 2012, 185, 1, 129

    CrossRef

  28. 28
    Kaushik Bharati, Sudhanshu Vrati, Viral Vaccines in India: An Overview, Proceedings of the National Academy of Sciences, India Section B: Biological Sciences, 2012, 82, 1, 181

    CrossRef

  29. 29
    Beth-Ann G Coller, David E Clements, Dengue vaccines: progress and challenges, Current Opinion in Immunology, 2011, 23, 3, 391

    CrossRef

  30. 30
    D. R. Martins, A. C. Pelizon, S. F. G. Zorzella-Pezavento, J. Seger, R. R. Santos Junior, D. M. Fonseca, L. A. Justulin Jr, C. L. Silva, A. Sartori, Exposure to Mycobacterium avium Decreases the Protective Effect of the DNA Vaccine pVAXhsp65 Against Mycobacterium tuberculosis-Induced Inflammation of the Pulmonary Parenchyma, Scandinavian Journal of Immunology, 2011, 73, 4
  31. 31
    Brian R. Murphy, Stephen S. Whitehead, Immune Response to Dengue Virus and Prospects for a Vaccine*, Annual Review of Immunology, 2011, 29, 1, 587

    CrossRef

  32. 32
    Wan-Lin Wu, Ling-Jun Ho, Pei-Chih Chen, Yi-Ting Tsai, Seng-Ting Hsu, Deh-Ming Chang, Jenn-Haung Lai, Immunosuppressive Effects and Mechanisms of Leflunomide in Dengue Virus Infection of Human Dendritic Cells, Journal of Clinical Immunology, 2011, 31, 6, 1065

    CrossRef

  33. 33
    Peifang Sun, Karolis Bauza, Subhamoy Pal, Zhaodong Liang, Shuenn-jue Wu, Charmagne Beckett, Timothy Burgess, Kevin Porter, Infection and activation of human peripheral blood monocytes by dengue viruses through the mechanism of antibody-dependent enhancement, Virology, 2011, 421, 2, 245

    CrossRef

  34. 34
    Heather Friberg, Lynne Burns, Marcia Woda, Siripen Kalayanarooj, Timothy P Endy, Henry AF Stephens, Sharone Green, Alan L Rothman, Anuja Mathew, Memory CD8+ T cells from naturally acquired primary dengue virus infection are highly cross-reactive, Immunology and Cell Biology, 2011, 89, 1, 122

    CrossRef

  35. 35
    Cheng-Feng Qin, Hui Zhao, Zhong-Yu Liu, Tao Jiang, Yong-Qiang Deng, Xu-Dong Yu, Man Yu, E-De Qin, Retinoic acid inducible gene-I and melanoma differentiation-associated gene 5 are induced but not essential for dengue virus induced type I interferon response, Molecular Biology Reports, 2011, 38, 6, 3867

    CrossRef

  36. 36
    Breno M. Silva, Lirlândia P. Sousa, Alessandra C. Gomes-Ruiz, Flávia G. G. Leite, Mauro M. Teixeira, Flávio G. da Fonseca, Paulo F. P. Pimenta, Paulo C. P. Ferreira, Erna G. Kroon, Cláudio A. Bonjardim, The dengue virus nonstructural protein 1 (NS1) increases NF-κB transcriptional activity in HepG2 cells, Archives of Virology, 2011, 156, 7, 1275

    CrossRef

  37. 37
    Beth-Ann G. Coller, David E. Clements, Andrew J. Bett, Sangeetha L. Sagar, Jan H. Ter Meulen, The development of recombinant subunit envelope-based vaccines to protect against dengue virus induced disease, Vaccine, 2011, 29, 42, 7267

    CrossRef

  38. 38
    S. J. Thomas, The Necessity and Quandaries of Dengue Vaccine Development, Journal of Infectious Diseases, 2011, 203, 3, 299

    CrossRef

  39. 39
    Jamie Whitehorn, Cameron P. Simmons, The pathogenesis of dengue, Vaccine, 2011, 29, 42, 7221

    CrossRef

  40. 40
    Limei Liu, Yanping Tian, Na Gao, Zong tao Chen, Heng Zhang, Jing An, Application of antibodies against nonstructural protein 2B of dengue serotype 2 virus induced by DNA immunisation or recombinant protein NS 2B immunisation in BALB/c mice, Journal of Virological Methods, 2010, 163, 1, 10

    CrossRef

  41. 41
    Izabela A. Rodenhuis-Zybert, Jan Wilschut, Jolanda M. Smit, Dengue virus life cycle: viral and host factors modulating infectivity, Cellular and Molecular Life Sciences, 2010, 67, 16, 2773

    CrossRef

  42. 42
    Yang Xiao-meng, Jiang Li-fang, Tang Yun-xia, Yin Yue, Liu Wen-quan, Fang Dan-yun, Establishment and characterization of dengue virus type 2 nonstructural protein 1 specific T cell lines, Comparative Immunology, Microbiology and Infectious Diseases, 2010, 33, 6, e75

    CrossRef

  43. 43
    Barry T. Rouse, Sharvan Sehrawat, Immunity and immunopathology to viruses: what decides the outcome?, Nature Reviews Immunology, 2010, 10, 7, 514

    CrossRef

  44. 44
    T. Duangchinda, W. Dejnirattisai, S. Vasanawathana, W. Limpitikul, N. Tangthawornchaikul, P. Malasit, J. Mongkolsapaya, G. Screaton, Immunodominant T-cell responses to dengue virus NS3 are associated with DHF, Proceedings of the National Academy of Sciences, 2010, 107, 39, 16922

    CrossRef

  45. 45
    Kerrie Vaughan, Jason Greenbaum, Martin Blythe, Bjoern Peters, Alessandro Sette, Meta-analysis of All Immune Epitope Data in theFlavivirusGenus: Inventory of Current Immune Epitope Data Status in the Context of Virus Immunity and Immunopathology, Viral Immunology, 2010, 23, 3, 259

    CrossRef

  46. 46
    B. Joyce-Shaikh, M. E. Bigler, C.-C. Chao, E. E. Murphy, W. M. Blumenschein, I. E. Adamopoulos, P. G. Heyworth, S. Antonenko, E. P. Bowman, T. K. McClanahan, J. H. Phillips, D. J. Cua, Myeloid DAP12-associating lectin (MDL)-1 regulates synovial inflammation and bone erosion associated with autoimmune arthritis, Journal of Experimental Medicine, 2010, 207, 3, 579

    CrossRef

  47. 47
    Alison D. Augustine, M. Cristina Cassetti, Francis A. Ennis, Eva Harris, William H. Hildebrand, Patricia M. Repik, NIAID Workshop onFlavivirusImmunity, Viral Immunology, 2010, 23, 3, 235

    CrossRef

  48. 48
    Radhakrishna M. Pillai, Janaki M. Babu, Vinoda T. Jissa, S. Lakshmi, Shubhada V. Chiplunkar, M. Patkar, H. Tongaonkar, Krishnamurthy B. Reddy, Kumar N. Chakka, M. Siddiqui, Soma Roychoudury, Priya Abraham, Abraham Peedicayil, M. Gnanamony, J. Subashini, T. S. Ram, Bindu Dey, Neeta Singh, Archana Singh, S. K. Jain, R. S. Jayshree, Region-Wise Distribution of High-Risk Human Papillomavirus Types in Squamous Cell Carcinomas of the Cervix in India, International Journal of Gynecological Cancer, 2010, 20, 6, 1046

    CrossRef

  49. 49
    M. Cristina Cassetti, Anna Durbin, Eva Harris, Rebeca Rico-Hesse, John Roehrig, Alan Rothman, Stephen Whitehead, Ramya Natarajan, Catherine Laughlin, Report of an NIAID workshop on dengue animal models, Vaccine, 2010, 28, 26, 4229

    CrossRef

  50. 50
    Beatriz Sierra, Ana B. Perez, Katrin Vogt, Gissel Garcia, Kathrin Schmolke, Eglys Aguirre, Mayling Alvarez, Florian Kern, Gustavo Kourí, Hans-Dieter Volk, Maria G. Guzman, Secondary heterologous dengue infection risk: Disequilibrium between immune regulation and inflammation?, Cellular Immunology, 2010, 262, 2, 134

    CrossRef

  51. 51
    Tanya Parkinson, David C Pryde, Small molecule drug discovery for Dengue and West Nile viruses: applying experience from hepatitis C virus, Future Medicinal Chemistry, 2010, 2, 7, 1181

    CrossRef

  52. 52
    Silvio Urcuqui-Inchima, Claudia Patiño, Silvia Torres, Anne-Lise Haenni, Francisco Javier Díaz, 2010,

    CrossRef

  53. 53
    DAVID W. VAUGHN, ALAN BARRETT, TOM SOLOMON, Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 2010,

    CrossRef

  54. You have free access to this content54
    Sansanee Noisakran, Kulkanya Chokephaibulkit, Pucharee Songprakhon, Nattawat Onlamoon, Hui-Mien Hsiao, Francois Villinger, Aftab Ansari, Guey Chuen Perng, A Re-evaluation of the Mechanisms Leading to Dengue Hemorrhagic Fever, Annals of the New York Academy of Sciences, 2009, 1171,
  55. 55
    Rebeca Rico-Hesse, Dengue virus markers of virulence and pathogenicity, Future Virology, 2009, 4, 6, 581

    CrossRef

  56. 56
    Daniel P Webster, Jeremy Farrar, Sarah Rowland-Jones, Progress towards a dengue vaccine, The Lancet Infectious Diseases, 2009, 9, 11, 678

    CrossRef

  57. 57
    Scott B. Halstead, Dengue: A Water-Borne Disease,